Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales

The disrupted introduction of the HPV-based cervical screening program in several jurisdictions has demonstrated that the attitudes and beliefs of screening-eligible persons are critically implicated in the success of program implementation (including the use of self-sampling). As no up-to-date and validated measures exist measuring attitudes and beliefs towards HPV testing and self-sampling, this study aimed to develop and validate two scales measuring these factors. In October-November 2021, cervical screening-eligible Canadians participated in a web-based survey. In total, 44 items related to HPV testing and 13 items related to HPV self-sampling attitudes and beliefs were included in the survey. For both scales, the optimal number of factors was identified using Exploratory Factor Analysis (EFA) and parallel analysis. Item Response Theory (IRT) was applied within each factor to select items. Confirmatory Factor Analysis (CFA) was used to assess model fit. After data cleaning, 1027 responses were analyzed. The HPV Testing Attitudes and Beliefs Scale (HTABS) had four factors, and twenty-two items were retained after item reduction. The HPV Self-sampling Attitudes and Beliefs Scale (HSABS) had two factors and seven items were retained. CFA showed a good model fit for both final scales. The developed scales will be a valuable resource to examine attitudes and beliefs in anticipation of, and to evaluate, HPV test-based cervical screening.

[1]  E. McBride,et al.  Development and validation of the cervical cancer knowledge scale and HPV testing knowledge scale in a sample of Canadian women , 2022, Preventive medicine reports.

[2]  C. Schmucker,et al.  Women’s attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review , 2022, BMJ Sexual & Reproductive Health.

[3]  Z. Rosberger,et al.  Assessing Canadian women's preferences for cervical cancer screening: A brief report , 2022, Frontiers in Public Health.

[4]  M. Poljak,et al.  Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis , 2022, The Lancet. Global health.

[5]  G. Zimet,et al.  Ensuring a Successful Transition From Cytology to Human Papillomavirus–Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women’s Intentions: Protocol for an Observational Study , 2022, JMIR research protocols.

[6]  L. Marlow,et al.  Testing key messages about extending cervical screening intervals , 2022, medRxiv.

[7]  L. Marlow,et al.  Acceptability of extending HPV-based cervical screening intervals from 3 to 5 years: an interview study with women in England , 2022, BMJ Open.

[8]  S. Sangrajrang,et al.  The IARC Perspective on Cervical Cancer Screening. , 2021, The New England journal of medicine.

[9]  R. Guy,et al.  Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis , 2021, BMC Public Health.

[10]  C. Kennedy,et al.  HPV self-sampling for cervical cancer screening: a systematic review of values and preferences , 2021, BMJ Global Health.

[11]  A. Tong,et al.  Indigenous Australian women's experiences of participation in cervical screening , 2020, PloS one.

[12]  M. Poljak,et al.  Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC) , 2020, British Journal of Cancer.

[13]  Lauren Rockliffe,et al.  Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis , 2020, Health psychology review.

[14]  J. Oliffe,et al.  Bridging Barriers to Cervical Cancer Screening in Transgender Men: A Scoping Review , 2020, American journal of men's health.

[15]  C. Borgfeldt,et al.  Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection , 2020, Infectious Agents and Cancer.

[16]  Jacob J. Coutts,et al.  Use Omega Rather than Cronbach’s Alpha for Estimating Reliability. But… , 2020 .

[17]  M. Poljak,et al.  Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  J. Waller,et al.  Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening. , 2020, Journal of women's health.

[19]  M. Macdonald,et al.  HPV Self-sampling in Indigenous Communities: A Scoping Review , 2019, Journal of Immigrant and Minority Health.

[20]  Jacques Ferlay,et al.  Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis , 2019, The Lancet. Global health.

[21]  L. Marlow,et al.  The psychosexual impact of testing positive for high‐risk cervical human papillomavirus (HPV): A systematic review , 2019, Psycho-oncology.

[22]  Megan A. Smith,et al.  Lessons from the renewal of the National Cervical Screening Program in Australia. , 2019, Public health research & practice.

[23]  K. McCaffery,et al.  A Thematic Analysis of Attitudes Toward Changes to Cervical Screening in Australia , 2019, JMIR cancer.

[24]  G. Zimet,et al.  Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis. , 2018, Preventive medicine.

[25]  E. Franco,et al.  Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial , 2018, JAMA.

[26]  A. Lofters,et al.  HPV self-sampling: A promising approach to reduce cervical cancer screening disparities in Canada. , 2018, Current oncology.

[27]  C. Bonner,et al.  ‘It has saved thousands of lives, so why change it?’ Content analysis of objections to cervical screening programme changes in Australia , 2018, BMJ Open.

[28]  Pamela Wakewich,et al.  Self-administered versus provider-directed sampling in the Anishinaabek Cervical Cancer Screening Study (ACCSS): a qualitative investigation with Canadian First Nations women , 2017, BMJ Open.

[29]  A. Lofters,et al.  Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review. , 2017, Canadian family physician Medecin de famille canadien.

[30]  Kelly Ackerson,et al.  Psychometric Testing of the Pap Smear Belief Questionnaire: Measuring Women’s Attitudes and Beliefs Toward Cervical Cancer Screening , 2017, Journal of Nursing Measurement.

[31]  S. Reisner,et al.  Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests. , 2017, LGBT health.

[32]  Brandy R. Maynard,et al.  The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis , 2016, Sexually Transmitted Infections.

[33]  D. Gesink,et al.  Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing. , 2016, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[34]  A. Burke,et al.  Patient Concerns About Human Papillomavirus Testing and 5-Year Intervals in Routine Cervical Cancer Screening , 2015, Obstetrics and gynecology.

[35]  A. Anttila,et al.  Self-sampling experiences among non-attendees to cervical screening. , 2014, Gynecologic oncology.

[36]  B. Rimer,et al.  Women's intentions to receive cervical cancer screening with primary human papillomavirus testing , 2013, International journal of cancer.

[37]  R. Hall,et al.  Beliefs about cervical cancer and Pap test: a new Chilean questionnaire. , 2013, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[38]  L. Bradford,et al.  Cervical cancer screening and prevention in low-resource settings. , 2013, Clinical obstetrics and gynecology.

[39]  A. Meade,et al.  Identifying careless responses in survey data. , 2012, Psychological methods.

[40]  C. Açikel,et al.  Health Belief Model Scale for Cervical Cancer and Pap Smear Test: psychometric testing. , 2011, Journal of advanced nursing.

[41]  L. Lohfeld,et al.  Barriers to Acceptance of Self-sampling for Human Papillomavirus across Ethnolinguistic Groups of Women , 2009, Canadian journal of public health = Revue canadienne de sante publique.

[42]  C. Tufanaru,et al.  Health Belief Model , 2009 .

[43]  Rhodri Hayward,et al.  Screening , 2008, The Lancet.

[44]  Michael R. Mullen,et al.  Structural equation modelling: guidelines for determining model fit , 2008 .

[45]  Stephen D Walter,et al.  Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. , 2007, The New England journal of medicine.

[46]  D. Bernstein,et al.  Acceptability of human papillomavirus self testing in female adolescents , 2005, Sexually Transmitted Infections.

[47]  B P O'Connor,et al.  SPSS and SAS programs for determining the number of components using parallel analysis and Velicer’s MAP test , 2000, Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc.

[48]  P. Bentler,et al.  Cutoff criteria for fit indexes in covariance structure analysis : Conventional criteria versus new alternatives , 1999 .

[49]  I. Ajzen The theory of planned behavior , 1991 .

[50]  I. Ajzen,et al.  Belief, Attitude, Intention, and Behavior: An Introduction to Theory and Research , 1977 .